VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q77416588  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000229.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q77416588‏
024 ‎‡a  0000-0002-8845-794X‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q77416588‏
100 0 ‎‡a  Patrícia Dias-Pereira‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  P Dias Pereira‏ ‎‡c  onderzoeker‏ ‎‡9  nl‏
670 ‎‡a  Author's A femorotibial joint swelling with popliteal lymph node enlargement in a Rottweiler‏
670 ‎‡a  Author's A salivary malignant myoepithelioma in a dog.‏
670 ‎‡a  Author's Activation of Mammalian target of rapamycin in canine mammary carcinomas: an immunohistochemical study.‏
670 ‎‡a  Author's Acute phase proteins and biomarkers of oxidative status in feline spontaneous malignant mammary tumours‏
670 ‎‡a  Author's Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas - A retrospective study of 137 cases‏
670 ‎‡a  Author's Canine mammary tumor risk is associated with polymorphisms in RAD51 and STK11 genes‏
670 ‎‡a  Author's Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study‏
670 ‎‡a  Author's Case of malignant biphasic mesothelioma in a dog‏
670 ‎‡a  Author's Catechol-o-methyltransferase genotypes are associated with progression and biological behaviour of canine mammary tumours‏
670 ‎‡a  Author's Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study‏
670 ‎‡a  Author's Characterization of α-, β- and p120-Catenin Expression in Feline Mammary Tissues and their Relation with E- and P-Cadherin.‏
670 ‎‡a  Author's Clinicopathological significance of immunoexpression of claudin-1 and claudin-7 in feline mammary carcinomas.‏
670 ‎‡a  Author's Coccidioidomycosis in a cat imported from the USA to Portugal.‏
670 ‎‡a  Author's COX-2 Expression in Canine Normal and Neoplastic Mammary Gland‏
670 ‎‡a  Author's Estrogen receptors genotypes and canine mammary neoplasia‏
670 ‎‡a  Author's Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors.‏
670 ‎‡a  Author's Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue‏
670 ‎‡a  Author's Feline plasma cell pododermatitis: a study of 8 cases.‏
670 ‎‡a  Author's Influence of catechol-O-methyltransferase‏
670 ‎‡a  Author's Influence of catechol-O-methyltransferase (COMT) genotypes on the prognosis of canine mammary tumors.‏
670 ‎‡a  Author's Influence of E-cadherin genetic variation in canine mammary tumour risk, clinicopathological features and prognosis‏
670 ‎‡a  Author's Interobserver Reproducibility of Histological Grading of Canine Simple Mammary Carcinomas.‏
670 ‎‡a  Author's Malignant canine mammary tumours: Preliminary genomic insights using oligonucleotide array comparative genomic hybridisation analysis.‏
670 ‎‡a  Author's Pathology in Practice‏
670 ‎‡a  Author's Recurrent and metastatic canine urethral transitional cell carcinoma without bladder involvement‏
670 ‎‡a  Author's Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas.‏
670 ‎‡a  Author's Renal Interstitial Lipid Accumulation in Cats with Chronic Kidney Disease‏
670 ‎‡a  Author's Single Nucleotide Polymorphisms Influence Histological Type and Grade of Canine Malignant Mammary Tumours‏
670 ‎‡a  Author's The in vivo performance of an alkali-free bioactive glass for bone grafting, FastOs® BG, assessed with an ovine model.‏
670 ‎‡a  Author's Use of the optical disector in canine mammary simple and complex carcinomas‏
670 ‎‡a  Author's Value of the Nottingham Histological Grading Parameters and Nottingham Prognostic Index in Canine Mammary Carcinoma‏
670 ‎‡a  Author's What is your diagnosis? Cutaneous ulcerated nodule in a geriatric dog.‏
909 ‎‡a  (orcid) 000000028845794x‏ ‎‡9  1‏
912 ‎‡a  pathologyinpractice‏ ‎‡A  Pathology in Practice‏ ‎‡9  1‏
919 ‎‡a  reducedexpressionofclaudin2isassociatedwithhighhistologicalgradeandmetastasisoffelinemammarycarcinomas‏ ‎‡A  Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas.‏ ‎‡9  1‏
919 ‎‡a  whatisyourdiagnosiscutaneousulceratednoduleinageriatricdog‏ ‎‡A  What is your diagnosis? Cutaneous ulcerated nodule in a geriatric dog.‏ ‎‡9  1‏
919 ‎‡a  valueofthenottinghamhistologicalgradingparametersandnottinghamprognosticindexincaninemammarycarcinoma‏ ‎‡A  Value of the Nottingham Histological Grading Parameters and Nottingham Prognostic Index in Canine Mammary Carcinoma‏ ‎‡9  1‏
919 ‎‡a  useoftheopticaldisectorincaninemammarysimpleandcomplexcarcinomas‏ ‎‡A  Use of the optical disector in canine mammary simple and complex carcinomas‏ ‎‡9  1‏
919 ‎‡a  invivoperformanceofanalkalifreebioactiveglassforbonegraftingfastosbgassessedwithanovinemodel‏ ‎‡A  The in vivo performance of an alkali-free bioactive glass for bone grafting, FastOs® BG, assessed with an ovine model.‏ ‎‡9  1‏
919 ‎‡a  singlenucleotidepolymorphismsinfluencehistologicaltypeandgradeofcaninemalignantmammarytumours‏ ‎‡A  Single Nucleotide Polymorphisms Influence Histological Type and Grade of Canine Malignant Mammary Tumours‏ ‎‡9  1‏
919 ‎‡a  renalinterstitiallipidaccumulationincatswithchronickidneydisease‏ ‎‡A  Renal Interstitial Lipid Accumulation in Cats with Chronic Kidney Disease‏ ‎‡9  1‏
919 ‎‡a  femorotibialjointswellingwithpopliteallymphnodeenlargementinarottweiler‏ ‎‡A  A femorotibial joint swelling with popliteal lymph node enlargement in a Rottweiler‏ ‎‡9  1‏
919 ‎‡a  salivarymalignantmyoepitheliomainadog‏ ‎‡A  A salivary malignant myoepithelioma in a dog.‏ ‎‡9  1‏
919 ‎‡a  activationofmammaliantargetofrapamycinincaninemammarycarcinomasanimmunohistochemicalstudy‏ ‎‡A  Activation of Mammalian target of rapamycin in canine mammary carcinomas: an immunohistochemical study.‏ ‎‡9  1‏
919 ‎‡a  acutephaseproteinsandbiomarkersofoxidativestatusinfelinespontaneousmalignantmammarytumours‏ ‎‡A  Acute phase proteins and biomarkers of oxidative status in feline spontaneous malignant mammary tumours‏ ‎‡9  1‏
919 ‎‡a  adjuvantdoxorubicinvsmetronomiccyclophosphamideandmeloxicamvssurgeryaloneforcatswithmammarycarcinomasaretrospectivestudyof137cases‏ ‎‡A  Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas - A retrospective study of 137 cases‏ ‎‡9  1‏
919 ‎‡a  caninemammarytumorriskisassociatedwithpolymorphismsinrad51andstk11genes‏ ‎‡A  Canine mammary tumor risk is associated with polymorphisms in RAD51 and STK11 genes‏ ‎‡9  1‏
919 ‎‡a  caninemammarytumorscomparisonofclassificationandgradingmethodsinasurvivalstudy‏ ‎‡A  Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study‏ ‎‡9  1‏
919 ‎‡a  caseofmalignantbiphasicmesotheliomainadog‏ ‎‡A  Case of malignant biphasic mesothelioma in a dog‏ ‎‡9  1‏
919 ‎‡a  catecholomethyltransferasegenotypesareassociatedwithprogressionandbiologicalbehaviourofcaninemammarytumours‏ ‎‡A  Catechol-o-methyltransferase genotypes are associated with progression and biological behaviour of canine mammary tumours‏ ‎‡9  1‏
919 ‎‡a  cellproliferationinfelinenormalhyperplasticandneoplasticmammarytissueanimmunohistochemicalstudy‏ ‎‡A  Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study‏ ‎‡9  1‏
919 ‎‡a  characterizationofαβandp120cateninexpressioninfelinemammarytissuesandtheirrelationwitheandpcadherin‏ ‎‡A  Characterization of α-, β- and p120-Catenin Expression in Feline Mammary Tissues and their Relation with E- and P-Cadherin.‏ ‎‡9  1‏
919 ‎‡a  clinicopathologicalsignificanceofimmunoexpressionofclaudin1andclaudin7infelinemammarycarcinomas‏ ‎‡A  Clinicopathological significance of immunoexpression of claudin-1 and claudin-7 in feline mammary carcinomas.‏ ‎‡9  1‏
919 ‎‡a  coccidioidomycosisinacatimportedfromtheusatoportugal‏ ‎‡A  Coccidioidomycosis in a cat imported from the USA to Portugal.‏ ‎‡9  1‏
919 ‎‡a  cox2expressionincaninenormalandneoplasticmammarygland‏ ‎‡A  COX-2 Expression in Canine Normal and Neoplastic Mammary Gland‏ ‎‡9  1‏
919 ‎‡a  estrogenreceptorsgenotypesandcaninemammaryneoplasia‏ ‎‡A  Estrogen receptors genotypes and canine mammary neoplasia‏ ‎‡9  1‏
919 ‎‡a  estrogensmetabolismassociatedwithpolymorphismsinfluenceofcomtg482agenotypeonageatonsetofcaninemammarytumors‏ ‎‡A  Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors.‏ ‎‡9  1‏
919 ‎‡a  expressionofecadherininnormalhyperplasticandneoplasticfelinemammarytissue‏ ‎‡A  Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue‏ ‎‡9  1‏
919 ‎‡a  felineplasmacellpododermatitisastudyof8cases‏ ‎‡A  Feline plasma cell pododermatitis: a study of 8 cases.‏ ‎‡9  1‏
919 ‎‡a  influenceofcatecholomethyltransferase‏ ‎‡A  Influence of catechol-O-methyltransferase‏ ‎‡9  1‏
919 ‎‡a  influenceofcatecholomethyltransferasecomtgenotypesontheprognosisofcaninemammarytumors‏ ‎‡A  Influence of catechol-O-methyltransferase (COMT) genotypes on the prognosis of canine mammary tumors.‏ ‎‡9  1‏
919 ‎‡a  influenceofecadheringeneticvariationincaninemammarytumourriskclinicopathologicalfeaturesandprognosis‏ ‎‡A  Influence of E-cadherin genetic variation in canine mammary tumour risk, clinicopathological features and prognosis‏ ‎‡9  1‏
919 ‎‡a  interobserverreproducibilityofhistologicalgradingofcaninesimplemammarycarcinomas‏ ‎‡A  Interobserver Reproducibility of Histological Grading of Canine Simple Mammary Carcinomas.‏ ‎‡9  1‏
919 ‎‡a  malignantcaninemammarytumourspreliminarygenomicinsightsusingoligonucleotidearraycomparativegenomichybridisationanalysis‏ ‎‡A  Malignant canine mammary tumours: Preliminary genomic insights using oligonucleotide array comparative genomic hybridisation analysis.‏ ‎‡9  1‏
919 ‎‡a  recurrentandmetastaticcanineurethraltransitionalcellcarcinomawithoutbladderinvolvement‏ ‎‡A  Recurrent and metastatic canine urethral transitional cell carcinoma without bladder involvement‏ ‎‡9  1‏
996 ‎‡2  DNB|1145675352‏
996 ‎‡2  ISNI|0000000389544321‏
996 ‎‡2  PTBNP|1656202‏
996 ‎‡2  ISNI|000000039084687X‏
996 ‎‡2  PTBNP|1333267‏
996 ‎‡2  PTBNP|1671651‏
996 ‎‡2  PTBNP|1629078‏
996 ‎‡2  ISNI|0000000070313775‏
996 ‎‡2  PTBNP|959002‏
996 ‎‡2  RERO|A003681730‏
996 ‎‡2  ISNI|0000000069482758‏
996 ‎‡2  NTA|128950358‏
996 ‎‡2  PTBNP|1437155‏
996 ‎‡2  DNB|1218809256‏
996 ‎‡2  PTBNP|1689767‏
996 ‎‡2  LC|no2023120082‏
996 ‎‡2  PTBNP|1378270‏
996 ‎‡2  SUDOC|232342954‏
996 ‎‡2  J9U|987007359553305171‏
996 ‎‡2  SUDOC|198689306‏
996 ‎‡2  BIBSYS|90526208‏
996 ‎‡2  LC|n 2024254979‏
996 ‎‡2  DNB|1296641902‏
996 ‎‡2  ISNI|0000000069225575‏
996 ‎‡2  PLWABN|9811461526605606‏
996 ‎‡2  PLWABN|9812405947705606‏
996 ‎‡2  PTBNP|1461101‏
996 ‎‡2  ISNI|0000000069931525‏
996 ‎‡2  SUDOC|249826712‏
996 ‎‡2  BLBNB|000552924‏
996 ‎‡2  SUDOC|246843403‏
996 ‎‡2  PTBNP|1012073‏
996 ‎‡2  BLBNB|001575935‏
996 ‎‡2  ISNI|000000003181274X‏
996 ‎‡2  PTBNP|1386522‏
996 ‎‡2  ISNI|0000000068083181‏
996 ‎‡2  PTBNP|1381842‏
996 ‎‡2  BLBNB|000271849‏
996 ‎‡2  DNB|1217502335‏
996 ‎‡2  ISNI|000000007021278X‏
996 ‎‡2  BLBNB|001487377‏
996 ‎‡2  PTBNP|1472754‏
996 ‎‡2  LC|n 88601475‏
996 ‎‡2  SUDOC|223456918‏
996 ‎‡2  ISNI|0000000070537859‏
996 ‎‡2  LC|n 2018046375‏
996 ‎‡2  PTBNP|1872028‏
996 ‎‡2  ISNI|0000000391978313‏
996 ‎‡2  LC|no2016114070‏
996 ‎‡2  ISNI|0000000358140658‏
996 ‎‡2  PTBNP|938663‏
996 ‎‡2  LC|no2023028259‏
996 ‎‡2  PTBNP|1679979‏
996 ‎‡2  DNB|1199954365‏
996 ‎‡2  LC|n 2014203838‏
996 ‎‡2  BLBNB|001543614‏
996 ‎‡2  BLBNB|000539042‏
996 ‎‡2  PTBNP|1238423‏
996 ‎‡2  ISNI|0000000428245755‏
996 ‎‡2  ISNI|0000000431720422‏
996 ‎‡2  ISNI|0000000068093021‏
996 ‎‡2  LC|n 96067413‏
996 ‎‡2  SUDOC|09511291X‏
996 ‎‡2  PTBNP|910935‏
996 ‎‡2  LC|n 2015238058‏
996 ‎‡2  NTA|362927545‏
996 ‎‡2  PTBNP|1384153‏
996 ‎‡2  BLBNB|000537962‏
996 ‎‡2  PTBNP|1807530‏
996 ‎‡2  BNF|15002602‏
996 ‎‡2  ISNI|0000000069302219‏
996 ‎‡2  PTBNP|1692247‏
996 ‎‡2  BLBNB|000392374‏
996 ‎‡2  PTBNP|1245395‏
996 ‎‡2  PTBNP|1609331‏
996 ‎‡2  PTBNP|1536021‏
996 ‎‡2  PTBNP|147740‏
996 ‎‡2  LC|n 2010041704‏
996 ‎‡2  ISNI|0000000070306006‏
996 ‎‡2  LC|n 2011214013‏
996 ‎‡2  ISNI|0000000454195288‏
996 ‎‡2  NSK|000538313‏
996 ‎‡2  BNF|17940340‏
996 ‎‡2  LC|no2018010367‏
996 ‎‡2  SUDOC|18516546X‏
996 ‎‡2  PTBNP|1251518‏
996 ‎‡2  ISNI|0000000358625997‏
996 ‎‡2  ISNI|0000000082850201‏
996 ‎‡2  DNB|1213674271‏
996 ‎‡2  RERO|A012345950‏
996 ‎‡2  PTBNP|1862892‏
996 ‎‡2  SUDOC|125496389‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏